A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia

NCT04409262 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

649

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Pneumonia

Interventions

DRUG: Remdesivir
DRUG: Tocilizumab
DRUG: Placebo

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]